Top

Published in:

Open Access 01-12-2006 | Review

Alpha thalassaemia-mental retardation, X linked

Author: Richard Gibbons

Published in: Orphanet Journal of Rare Diseases | Issue 1/2006

Abstract

X-linked alpha thalassaemia mental retardation (ATR-X) syndrome in males is associated with profound developmental delay, facial dysmorphism, genital abnormalities and alpha thalassaemia. Female carriers are usually physically and intellectually normal. So far, 168 patients have been reported. Language is usually very limited. Seizures occur in about one third of the cases. While many patients are affectionate with their caregivers, some exhibit autistic-like behaviour. Patients present with facial hypotonia and a characteristic mouth. Genital abnormalities are observed in 80% of children and range from undescended testes to ambiguous genitalia. Alpha-thalassaemia is not always present. This syndrome is X-linked recessive and results from mutations in the ATRX gene. This gene encodes the widely expressed ATRX protein. ATRX mutations cause diverse changes in the pattern of DNA methylation at heterochromatic loci but it is not yet known whether this is responsible for the clinical phenotype. The diagnosis can be established by detection of alpha thalassaemia, identification of ATRX gene mutations, ATRX protein studies and X-inactivation studies. Genetic counselling can be offered to families. Management is multidisciplinary: young children must be carefully monitored for gastro-oesophageal reflux as it may cause death. A number of individuals with ATR-X are fit and well in their 30s and 40s.

Available only for authorised users

Carpenter NJ, Qu Y, Curtis M, Patil SR: X-linked mental retardation syndrome with characteristic "coarse" facial appearance, brachydactyly, and short stature maps to proximal Xq. Am J Med Genet. 1999, 85: 230-235. 10.1002/(SICI)1096-8628(19990730)85:3<230::AID-AJMG9>3.0.CO;2-O.CrossRefPubMed

Guerrini R, Shanahan JL, Carrozzo R, Bonanni P, Higgs DR, Gibbons RJ: A nonsense mutation of the ATRX gene causing mild mental retardation and epilepsy. Ann Neurol. 2000, 47: 117-121. 10.1002/1531-8249(200001)47:1<117::AID-ANA20>3.0.CO;2-A.CrossRefPubMed

Donnai D, Clayton-Smith J, Gibbons RJ, Higgs DR: The non-deletion alpha thalassaemia/mental retardation syndrome: further support for X linkage. J Med Genet. 1991, 28: 742-745.PubMedCentralCrossRefPubMed

Holmes LB, Gang DL: Brief clinical report: an X-linked mental retardation syndrome with craniofacial abnormalities, microcephaly and club foot. Am J Med Genet. 1984, 17: 375-382. 10.1002/ajmg.1320170131.CrossRefPubMed

Stevenson RE, Abidi F, Schwartz CE, Lubs HA, Holmes LB: Holmes-Gang syndrome is allelic with XLMR-hypotonic face syndrome. Am J Med Genet. 2000, 94: 383-385. 10.1002/1096-8628(20001023)94:5<383::AID-AJMG7>3.0.CO;2-7.CrossRefPubMed

Lossi AM, Millan JM, Villard L, Orellana C, Cardoso C, Prieto F, Fontes M, Martinez F: Mutation of the XNP/ATR-X gene in a family with severe mental retardation, spastic paraplegia and skewed pattern of X inactivation: demonstration that the mutation is involved in the inactivation bias. Am J Hum Genet. 1999, 65: 558-562. 10.1086/302499.PubMedCentralCrossRefPubMed

Saugier-Veber P, Munnich A, Lyonnet S, Toutain A, Moraine C, Piussan C, Mathieu M, Gibbons RJ: Lumping Juberg-Marsidi syndrome and X-linked alpha-thalassemia/mental retardation syndrome?. Am J Med Genet. 1995, 55: 300-301. 10.1002/ajmg.1320550310.CrossRefPubMed

Kurosawa K, Akatsuka A, Ochiai Y, Ikeda J, Maekawa K: Self-induced vomiting in X-linked alpha-thalassemia/mental retardation syndrome. Am J Med Genet. 1996, 63: 505-506. 10.1002/ajmg.1320630304.CrossRefPubMed

Wada T, Nakamura M, Matsushita Y, Yamada M, Yamashita S, Iwamoto H, Masuno M, Imaizumi K, Kuroki Y: [Three Japanese children with X-linked alpha-thalassemia/mental retardation syndrome (ATR-X)]. No To Hattatsu. 1998, 30: 283-289.PubMed

10.

Wilkie AO, Zeitlin HC, Lindenbaum RH, Buckle VJ, Fischel-Ghodsian N, Chui DH, Gardner-Medwin D, MacGillivray MH, Weatherall DJ, Higgs DR: Clinical features and molecular analysis of the alpha thalassemia/mental retardation syndromes.II. Cases without detectable abnormality of the alpha globin complex. Am J Hum Genet. 1990, 46: 1127-1140.PubMedCentralPubMed

11.

Ion A, Telvi L, Chaussain JL, Galacteros F, Valayer J, Fellous M, McElreavey K: A novel mutation in the putative DNA helicase XH2 is responsible for male-to-female sex reversal associated with an atypical form of the ATR-X syndrome. Am J Hum Genet. 1996, 58: 1185-1191.PubMedCentralPubMed

12.

McPherson EW, Clemens MM, Gibbons RJ, Higgs DR: X-linked alpha-thalassemia/mental retardation (ATR-X) syndrome: a new kindred with severe genital anomalies and mild hematologic expression. Am J Med Genet. 1995, 55: 302-306. 10.1002/ajmg.1320550311.CrossRefPubMed

13.

Reardon W, Gibbons RJ, Winter RM, Baraitser M: Male pseudohermaphroditism in sibs with the alpha-thalassemia/mental retardation (ATR-X) syndrome. Am J Med Genet. 1995, 55: 285-287. 10.1002/ajmg.1320550308.CrossRefPubMed

14.

Gibbons RJ, Brueton L, Buckle VJ, Burn J, Clayton-Smith J, Davison BC, Gardner RJ, Homfray T, Kearney L, Kingston HM, et al: Clinical and hematologic aspects of the X-linked alpha-thalassemia/mental retardation syndrome (ATR-X). Am J Med Genet. 1995, 55: 288-299. 10.1002/ajmg.1320550309.CrossRefPubMed

15.

Martucciello G, Lombardi L, Savasta S, Gibbons RJ: The Gastrointestinal Phenotype of ATR-X syndrome. Am J Med Genet. 2006

16.

Villard L, Toutain A, Lossi AM, Gecz J, Houdayer C, Moraine C, Fontes M: Splicing mutation in the ATR-X gene can lead to a dysmorphic mental retardation phenotype without alpha-thalassemia. Am J Hum Genet. 1996, 58: 499-505.PubMedCentralPubMed

17.

Villard L, Lacombe D, Fontes M: A point mutation in the XNP gene, associated with an ATR-X phenotype without alpha-thalassemia. Eur J Hum Genet. 1996, 4: 316-320.PubMed

18.

Gibbons RJ, Picketts DJ, Villard L, Higgs DR: Mutations in a putative global transcriptional regulator cause X-linked mental retardation with alpha-thalassemia (ATR-X syndrome). Cell. 1995, 80: 837-845. 10.1016/0092-8674(95)90287-2.CrossRefPubMed

19.

Picketts DJ, Higgs DR, Bachoo S, Blake DJ, Quarrell OW, Gibbons RJ: ATRX encodes a novel member of the SNF2 family of proteins: mutations point to a common mechanism underlying the ATR-X syndrome. Hum Mol Genet. 1996, 5: 1899-1907. 10.1093/hmg/5.12.1899.CrossRefPubMed

20.

Garrick D, Samara V, McDowell TL, Smith AJ, Dobbie L, Higgs DR, Gibbons RJ: A conserved truncated isoform of the ATR-X syndrome protein lacking the SWI/SNF-homology domain. Gene. 2004, 326: 23-34. 10.1016/j.gene.2003.10.026.CrossRefPubMed

21.

Xie S, Wang Z, Okano M, Nogami M, Li Y, He WW, Okumura K, Li E: Cloning, expression and chromosome locations of the human DNMT3 gene family. Gene. 1999, 236: 87-95. 10.1016/S0378-1119(99)00252-8.CrossRefPubMed

22.

Gibbons RJ, Higgs DR: Molecular-clinical spectrum of the ATR-X syndrome. Am J Med Genet. 2000, 97: 204-212. 10.1002/1096-8628(200023)97:3<204::AID-AJMG1038>3.0.CO;2-X.CrossRefPubMed

23.

McDowell TL, Gibbons RJ, Sutherland H, O'Rourke DM, Bickmore WA, Pombo A, Turley H, Gatter K, Picketts DJ, Buckle VJ, Chapman L, Rhodes D, Higgs DR: Localization of a putative transcriptional regulator (ATRX) at pericentromeric heterochromatin and the short arms of acrocentric chromosomes. Proc Natl Acad Sci USA. 1999, 96: 13983-13988. 10.1073/pnas.96.24.13983.PubMedCentralCrossRefPubMed

24.

Le Douarin B, Nielsen AL, Garnier J-M, Ichinose H, Jeanmougin F, Losson R, Chambon P: A possible involvement of TIF1α and TIF1β in the epigenetic control of transcription by nuclear receptors. EMBO Journal. 1996, 15: 6701-6715.PubMedCentralPubMed

25.

Berube NG, Smeenk CA, Picketts DJ: Cell cycle-dependent phosphorylation of the ATRX protein correlates with changes in nuclear matrix and chromatin association. Hum Mol Genet. 2000, 9: 539-547. 10.1093/hmg/9.4.539.CrossRefPubMed

26.

Xue Y, Gibbons R, Yan Z, Yang D, McDowell TL, Sechi S, Qin J, Zhou S, Higgs D, Wang W: The ATRX syndrome protein forms a chromatin-remodeling complex with Daxx and localizes in promyelocytic leukemia nuclear bodies. Proc Natl Acad Sci USA. 2003, 100: 10635-10640. 10.1073/pnas.1937626100.PubMedCentralCrossRefPubMed

27.

Ishov AM, Vladimirova OV, Maul GG: Heterochromatin and ND10 are cell-cycle regulated and phosphorylation-dependent alternate nuclear sites of the transcription repressor Daxx and SWI/SNF protein ATRX. J Cell Sci. 2004, 117: 3807-3820. 10.1242/jcs.01230.CrossRefPubMed

28.

Gibbons RJ, McDowell TL, Raman S, O'Rourke DM, Garrick D, Ayyub H, Higgs DR: Mutations in ATRX, encoding a SWI/SNF-like protein, cause diverse changes in the pattern of DNA methylation. Nat Genet. 2000, 24: 368-371. 10.1038/74191.CrossRefPubMed

29.

Garrick D, Sharpe JA, Arkell R, Dobbie L, Smith AJ, Wood WG, Higgs DR, Gibbons RJ: Loss of Atrx Causes Trophoblast Failure and is Associated with Escape from Imprinted X-inactivation. PLoS Genetics. 2006

30.

Berube NG, Mangelsdorf M, Jagla M, Vanderluit J, Garrick D, Gibbons RJ, Higgs DR, Slack RS, Picketts DJ: The chromatin-remodeling protein ATRX is critical for neuronal survival during corticogenesis. J Clin Invest. 2005, 115: 258-267. 10.1172/JCI200522329.PubMedCentralCrossRefPubMed

31.

Abidi FE, Cardoso C, Lossi AM, Lowry RB, Depetris D, Mattei MG, Lubs HA, Stevenson RE, Fontes M, Chudley AE, Schwartz CE: Mutation in the 5' alternatively spliced region of the XNP/ATR-X gene causes Chudley-Lowry syndrome. Eur J Hum Genet. 2005, 13: 176-183. 10.1038/sj.ejhg.5201303.CrossRefPubMed

32.

Howard MT, Malik N, Anderson CB, Voskuil JL, Atkins JF, Gibbons RJ: Attenuation of an amino-terminal premature stop codon mutation in the ATRX gene by an alternative mode of translational initiation. J Med Genet. 2004, 41: 951-956. 10.1136/jmg.2004.020248.PubMedCentralCrossRefPubMed

33.

Higgs DR, Vickers MA, Wilkie AO, Pretorius IM, Jarman AP, Weatherall DJ: A review of the molecular genetics of the human alpha-globin gene cluster. Blood. 1989, 73: 1081-1104.PubMed

34.

Villard L, Gecz J, Mattei JF, Fontes M, Saugier-Veber P, Munnich A, Lyonnet S: XNP mutation in a large family with Juberg-Marsidi syndrome. Nat Genet. 1996, 12: 359-360. 10.1038/ng0496-359.CrossRefPubMed

35.

Cardoso C, Lutz Y, Mignon C, Compe E, Depetris D, Mattei MG, Fontes M, Colleaux L: ATR-X mutations cause impaired nuclear location and altered DNA binding properties of the XNP/ATR-X protein. J Med Genet. 2000, 37: 746-751. 10.1136/jmg.37.10.746.PubMedCentralCrossRefPubMed

36.

Gibbons RJ, Suthers GK, Wilkie AO, Buckle VJ, Higgs DR: X-linked alpha-thalassemia/mental retardation (ATR-X) syndrome: localization to Xq12-q21.31 by X inactivation and linkage analysis. Am J Hum Genet. 1992, 51: 1136-1149.PubMedCentralPubMed

37.

Wada T, Sugie H, Fukushima Y, Saitoh S: Non-skewed X-inactivation may cause mental retardation in a female carrier of X-linked alpha-thalassemia/mental retardation syndrome (ATR-X): X-inactivation study of nine female carriers of ATR-X. Am J Med Genet A. 2005, 138: 18-20.CrossRefPubMed

38.

Plenge RM, Stevenson RA, Lubs HA, Schwartz CE, Willard HF: Skewed X-chromosome inactivation is a common feature of X-linked mental retardation disorders. Am J Hum Genet. 2002, 71: 168-173. 10.1086/341123.PubMedCentralCrossRefPubMed

39.

Abidi F, Schwartz CE, Carpenter NJ, Villard L, Fontes M, Curtis M: Carpenter-Waziri syndrome results from a mutation in XNP. Am J Med Genet. 1999, 85: 249-251. 10.1002/(SICI)1096-8628(19990730)85:3<249::AID-AJMG12>3.0.CO;2-U.CrossRefPubMed

40.

Villard L, Fontes M, Ades LC, Gecz J: Identification of a mutation in the XNP/ATR-X gene in a family reported as Smith-Fineman-Myers syndrome. Am J Med Genet. 2000, 91: 83-85. 10.1002/(SICI)1096-8628(20000306)91:1<83::AID-AJMG15>3.0.CO;2-N.CrossRefPubMed

41.

Bachoo S, Gibbons RJ: Germline and gonosomal mosaicism in the ATR-X syndrome. Eur J Hum Genet. 1999, 7: 933-936. 10.1038/sj.ejhg.5200387.CrossRefPubMed

Title: Alpha thalassaemia-mental retardation, X linked
Author: Richard Gibbons
Publication date: 01-12-2006
Publisher: BioMed Central
Published in: Orphanet Journal of Rare Diseases / Issue 1/2006
Electronic ISSN: 1750-1172
DOI: https://doi.org/10.1186/1750-1172-1-15

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Alpha thalassaemia-mental retardation, X linked

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2006

Walker-Warburg syndrome

Kikuchi-Fujimoto disease

Glanzmann thrombasthenia

Dopamine beta-hydroxylase deficiency

Immunodeficiency, centromeric region instability, facial anomalies syndrome (ICF)

Plummer-Vinson syndrome